Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: Case series.
Autoimmune
COVID-19
Encephalitis
Plasmapheresis
Journal
Brain, behavior, and immunity
ISSN: 1090-2139
Titre abrégé: Brain Behav Immun
Pays: Netherlands
ID NLM: 8800478
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
03
05
2020
revised:
05
05
2020
accepted:
06
05
2020
pubmed:
12
5
2020
medline:
7
7
2020
entrez:
12
5
2020
Statut:
ppublish
Résumé
Severe SARS-CoV-2 (COVID-19) infection has the potential for a high mortality rate. In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19-related autoimmune meningoencephalitis in the Intensive Care Unit (ICU).
Identifiants
pubmed: 32389697
pii: S0889-1591(20)30803-5
doi: 10.1016/j.bbi.2020.05.022
pmc: PMC7204750
pii:
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
155-158Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.